SUNPHARMA vs TATASTEEL: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows a higher ROE, faster revenue growth and lower leverage, while TATA STEEL shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUNPHARMA leads 7; TATASTEEL leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| Sector | Healthcare | Metals & Mining |
| Industry | Pharmaceuticals | Iron & Steel |
Price
| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| Live Price | ₹1,748 | ₹167.67 |
| Day Change | -0.57% | -2.7% |
| Volume | 10.65 L | 3.03 Cr |
| 52-Week High | ₹2,046.9 | ₹224.4 |
| 52-Week Low | ₹1,583.7 | ₹160.06 |
| Distance from 52W High | -14.6% | -25.28% |
Valuation
| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| Market Cap | ₹4.18 L Cr | ₹2.09 L Cr |
| P/E Ratio | 34.58x | 18.92x |
| P/B Ratio | 5x | 2.04x |
| EPS | ₹50.77 | ₹8.84 |
| Book Value | ₹348.31 | ₹81.84 |
| Dividend Yield | 0.92% | 2.32% |
Growth
| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.8% | 12.5% |
| EPS Growth (TTM YoY) | 25.6% | 125.2% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| ROE | 13.72% | 10.49% |
| ROCE | 15.12% | 8.2% |
| Net Margin | 18.56% | 4.69% |
| Operating Margin | 26.44% | 9.81% |
| Debt to Equity | 0.05x | 0.89x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SUNPHARMA | TATASTEEL |
|---|---|---|
| Promoter Holding | 52.68%▼ 1.8 pp | 32.94%▼ 0.25 pp |
| FII Holding | 14.36%▼ 0.17 pp | 19.37%▲ 0.32 pp |
| DII Holding | 22.27%▲ 0.09 pp | 26.62%▼ 0.23 pp |
| Public Holding | 10.7%▲ 1.89 pp | 21.05%▲ 0.15 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and TATA STEEL.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.